Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/1995
09/14/1995WO1995024398A1 Isoxazoline compounds as inhibitors of tnf release
09/14/1995WO1995024391A1 Piperidines and pyrrolidines
09/14/1995WO1995024389A1 Indole derivatives as cck receptor antagonists
09/14/1995WO1995024192A1 Isoxazoline compounds as 5-lipoxygenase inhibitors
09/14/1995WO1995024183A1 Methods and compositions for pulmonary delivery of insulin
09/14/1995CA2414016A1 Vascular endothelial growth factor 2
09/14/1995CA2184905A1 Corpuscles of stannius protein, stanniocalcin
09/14/1995CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995CA2184739A1 Thiazolidinedione derivatives as anti-hyperglycemic agents
09/14/1995CA2184686A1 Transgenic production of oligosaccharides and glycoconjugates
09/13/1995EP0671468A1 Lactic acid bacteria of the genus lactobacillus
09/13/1995EP0671392A1 Substituted propane derivatives, process for their preparation and use of the compounds for the treatment of illnesses
09/13/1995EP0671387A1 Fluorinated vitamin D3 derivative
09/13/1995EP0671171A1 Use of HMG COA reductase inhibitor for the manufacture of a medicament for proventing or reducing risks of onset of cardiovascular events
09/13/1995EP0671169A1 Nanoparticles containing an active agent and a cetal-tartanic acid amides polymer, process for preparation thereof and their use
09/13/1995EP0671005A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
09/13/1995EP0525167B1 Sustained drug release through topical application of bioadhesive liposomes
09/13/1995CN1108456A Benzothiazole compound, process for producing the same, and use thereof
09/13/1995CN1108254A Process for the preparation of alpha-tocopherol derivatives
09/13/1995CN1108244A Lactone compound and process of production thereof
09/13/1995CN1108090A Methods for inhibiting LDL oxidation and atherosclerosis
09/12/1995US5449814 Dehydration; Michael condensation
09/12/1995US5449798 Phospholipid derivatives containing higher elements of the fifth group
09/12/1995US5449674 Prostaglandin E2 inhibitors
09/12/1995CA2144218A1 Lipases immobilized in sol-gel processed hydrophobic materials
09/10/1995CA2144216A1 Nanoparticles containing an active substance and a ketalized polytartramidic acid, process for their preparation, and use thereof
09/08/1995WO1995023798A1 Prodrugs of morpholine tachykinin receptor antagonists
09/08/1995WO1995023792A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same
09/08/1995WO1995023791A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same
09/08/1995WO1995023783A1 Ketopanthenol with acetylating properties
09/08/1995WO1995023782A1 Calcium ketopantothenate with acetylating properties
09/08/1995CA2184112A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same
09/08/1995CA2184111A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same
09/08/1995CA2183754A1 Calcium ketopantothenate with acetylating properties
09/08/1995CA2183752A1 Ketopanthenol with acetylating properties
09/06/1995EP0670300A2 Process for the preparation of allyl quinone derivatives, and intermediates
09/06/1995EP0670162A1 Pharmaceutical formulations containing raloxifere, a surfactant and a watersoluble diluent
09/06/1995EP0669835A1 Dietary hypocholesterolaemic compositions comprising soya proteins and sitosterols
09/06/1995EP0669833A1 USES OF TGF-$g(b) RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT
09/06/1995EP0669830A1 Substituted dipeptide analogs promote release of growth hormone
09/06/1995EP0669827A1 Compositions for the regulation of cytokine activity
09/06/1995EP0669824A1 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
09/06/1995EP0656782A4 Nutritional product for persons having a neurological injury.
09/06/1995EP0594590B1 Ruminal bacterium for preventing acute lactic acidosis
09/06/1995EP0561815B1 Directly compressible xylitol and method
09/06/1995CN1107857A Cyclic amino acid derivativges
09/06/1995CN1107711A Hypoglycemic compound capsule
09/06/1995CN1107707A Methods for inhibiting weight gain or inducing weight loss
09/05/1995US5447954 Antilipidemic agents
09/05/1995US5447953 Biomasses to treat non-human animals
09/05/1995US5447951 Use of 3-indolepyruvic acid or its salt
09/05/1995US5447924 Vitamin D analogues
09/05/1995US5447922 α-phosphonosulfinic squalene synthetase inhibitors
09/05/1995US5447728 A carrier comprising an acylated amino acid; lowering iron concentration in mammals
09/05/1995US5447721 Solvent extraction of lichen culture; applying to skin; cosmetics
09/05/1995CA2010017C Composition for reparation and prevention of fibrotic lesions
09/05/1995CA1336913C Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase
09/05/1995CA1336911C Serotonin antagonists
09/05/1995CA1336906C Lactam derivatives
09/05/1995CA1336886C Phenethanolamine and growth hormone combinations
09/05/1995CA1336867C Nutrient mixture for the elderly
09/03/1995CA2143725A1 Process for the preparation of allyl quinone derivatives, and intermediates
09/03/1995CA2141999A1 Methods of use for inhibiting bone loss and lowering serum cholesterol
09/02/1995CA2143603A1 Fatty acid derivatives
08/1995
08/31/1995WO1995022971A1 Anti-inflammatory and infection protective effects of sesamin-based lignans
08/31/1995CA2183637A1 Anti-inflammatory and infection protective effects of sesamin-based lignans
08/30/1995EP0668854A1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacentates or n, n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
08/30/1995EP0668785A1 System employing a sterile medical solution containing glucose or glucose-like compounds and a solution intended for said system
08/30/1995EP0668773A1 Improved fish production
08/30/1995EP0668771A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs
08/30/1995EP0668770A1 $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
08/30/1995EP0668760A1 Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo
08/30/1995EP0631500A4 1-g(a)-HYDROXY-24--i(EPI)-VITAMIN D 4?.
08/30/1995EP0485577B1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
08/30/1995CN1107639A Pyridothiazineacetic acid compound, process for producing the same, and use thereof
08/30/1995CN1107363A Alcohol or aldehyde derivatives and their use
08/30/1995CN1107359A Galenic composition
08/29/1995US5446131 Polypeptides or cylic polypeptide; therapeutic and prophylactic; inhibit thrombin-induced platelet aggregation
08/29/1995US5446071 Administering anticholesterol agents
08/29/1995US5446061 Methods for lowering serum cholesterol
08/29/1995US5446054 Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
08/29/1995US5446046 1,3-dipropyl-8-(3-oxatricyclo(3,1,2,0(2,4-))oct6(7)-Yl)-xanthine used to treat cadiac arrhythmias
08/29/1995US5446035 Stabilize blood calcium and phosphate levels, induce cell differentiation
08/29/1995US5446034 Vitamin D analogues
08/29/1995CA2059840C Composition for the treatment of diabetes
08/29/1995CA2002558C Copper complexes of alpha-amino acids that contain terminal amino acid groups, and their use as nutritional supplements
08/29/1995CA1336835C Benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
08/29/1995CA1336815C Method for preventing secondary effects
08/29/1995CA1336814C Reduction of low density lipoproteins in biological fluids
08/24/1995WO1995022611A2 Methods and compositions for stimulating bone cells
08/24/1995WO1995022348A1 Medical application of bromelain
08/24/1995WO1995022339A1 Cyclic heptapeptide anti-inflammatory agent
08/24/1995CA2183866A1 Medical application of bromelain
08/24/1995CA2181827A1 Cyclic heptapeptide anti-inflammatory agent
08/23/1995EP0668278A1 Adhesion receptor antagonists
08/23/1995EP0667914A1 Fo-1289 substance and its production
08/23/1995EP0667860A1 Aza spiro alkanes derivatives as therapeutic agents
08/23/1995EP0667787A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
08/23/1995CN1107158A Polysubstituted 2-amino-thiazole derivatives
08/23/1995CN1107154A Chloride substituted imidazole derivative
1 ... 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 ... 1298